Study #2020-0785
A Phase 1 Study of TAS0612 in Patients with Locally Advanced or Metastatic Solid Tumors
MD Anderson Study Status
Not Accepting
Treatment Agent
TAS0612
Description
The purpose of this study is to see if TAS0612 is safe in participants with advanced or metastatic solid tumor cancer.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Advanced or Metastatic Solid Tumors
Study phase:
Phase I
Physician name:
Funda Meric-Bernstam
Department:
Investigational Cancer Therapeutics
For general questions about clinical trials:
1-855-760-2503
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.